United States

Grindeks AS (GRD1R.RI)

GRD1R.RI on Riga Stock Exchange

2 Dec 2016
Change (% chg)

Ls 0.04 (+0.84%)
Prev Close
Ls 4.75
Ls 4.78
Day's High
Ls 4.79
Day's Low
Ls 4.75
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Grindeks H1 net sales up at EUR 46.4 mln
Friday, 26 Aug 2016 09:26am EDT 

Grindeks AS : H1 net sales 46.4 million euros ($52.39 million) versus 43.8 million euros year ago .H1 net profit 4.6 million euros versus 3.5 million euros year ago.  Full Article

Grindeks AS Q1 net profit shrinks to EUR 50,223
Friday, 27 May 2016 11:00am EDT 

Grindeks AS : Q1 net sales 20.8 million euros ($23.15 million) versus 22.4 million euros year ago .Q1 net profit 50,223 euros versus 1.5 million euros year ago.  Full Article

Grindeks AS supplies oxytocin injections to World Health Organization
Thursday, 24 Sep 2015 12:39am EDT 

Grindeks AS:Says has concluded a long-term cooperation agreement with World Health Organization (WHO) on oxytocin supplies.In accordance with the conditions of the contract the first consignment of oxytocin injections will be delivered to North Korea and Comoro Islands.The next closest consignments will reach Nigeria and Cote d'Ivoire.  Full Article

Grindeks AS announces changes in shareholding structure
Friday, 17 Jul 2015 08:32am EDT 

Grindeks AS:ABLV Private Equity Fund 2010, KS on July 15 lost a significant direct shareholding in JSC Grindeks by losing its proportion of voting rights from 2,172,437 shares, or 22.66 pct of total share capital.Says after concluded transactions on July 15 AmberStone Group, AS owns 2,172,437 shares of JSC Grindeks or 22.66 pct of all JSC Grindeks voting rights.  Full Article